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Analysis of the hospitalization causes in patients with a 
permanent form of atrial fibrillation, arterial hypertension, 
stable coronary artery disease and heart failure 
 
MI Yalovenko, OO Khaniukov and YED Yehudina  
 
Abstract 
Aim of the study was to determine the reasons for hospital admission in patients with a permanent form 
of atrial fibrillation (AF). We have examined 42 patients with permanent form of AF, arterial 
hypertension (AH), stable coronary artery disease (SCAD) and heart failure (HF). Results: It was found 
that in the presence of the previous year admissions, the chances of admission frequencies increased in 
82.8 times. Provided that the risk of patient’s readmission in presenting of atrial fibrillation-related 
symptoms (EHRA score) ≥ 1 and New York heart association (NYHA) functional classification of 
breathlessness (NYHA FC) ≥ 2 increases by 15 times, of unstable angina - by 5,7 times. If the patients 
have high-sensitivity C-reactive protein (hs-CRP) more than 4.16 mg/L, the risk of readmission increases 
by 15.0 times. If the patients have interleukins (IL) IL-6 is more than 8.35 pg / mL risk increases by 7.5 
times. If patients have IL-10 ≥ 35.3 pg / ml, the risk increases by 15.0 times. 
 




Atrial fibrillation (AF) is new millennium epidemic that affects millions of lives, mostly 
affecting the middle-aged and elderly [1]. European countries have an aging population that is 
growing rapidly [2]. This arrhythmia affects over 886,000 new people each year in Europe. By 
2030, the number people with AF is expected to increase up to 70 % [3].  
Patients with AF have an increases risk for life-threatening complications and other diseases: 
heat failure (HF) increased by 5 times, stroke increased by 2, 4 times and cardiovascular 
mortality increased by 2 times [4]. AF increasingly places a critical financial burden on the 
healthcare system, costing €660 - € 3,286 million annually across European countries [5, 6]. 
Healthcare resource use in AF patients is high, with up to 40% of AF patients hospitalized 
each year primarily due to heart failure and arrhythmia recurrence [7, 8]. Hospitalization costs 
can be 2× higher for persistent AF than paroxysmal AF [8]. 
Costs for AF management can be divided into 2 groups: direct costs (hospitalization, 
outpatient and physician visits, prescriptions, laboratory testing, long-term care) and indirect 
costs (work productivity losses, support provided by caregivers). 
Estimate suggested that over the next 12 years, there will be a 70 % increase in the number of 
people affected by AF, the number medical visits is expected to increase by: 3.5-4 million 
hospitalizations for AF, 100-120 million outpatient visits [9, 10]. 
Thus aim of the study was to determine the anamnestic, clinical and laboratory factors which 
influence the frequency of admission to the cardiological department. 
 
2. Materials and Methods 
We have examined 42 patients (average age was 68,0 ± 1,2 years) with permanent form of AF, 
arterial hypertension (AH), coronary artery disease (CAD) and HF who were admitted to the 
cardiology department. The median follow-up of AF in the examined group is 9,5 years [7,0-
13,0]: 3 (7.1 %) patients have had the permanent form AF diagnosed up to 5 years, 18 (42.9 
%) patients have suffered from AF up to 10 years, 12 (28.6 %) - up to 15 years, 9 (21.4 %) 
have had the permanent form of AF more than 15 years. AF was associated with the 1st stage 
of AH in 21 (50.0 %) cases, the 2nd stage-in 21 (50.0 %). The study excluded patients with the 
valvular heart disease, the 3d stage of hypertension (systolic BP ≥ 180 mmHg or diastolic BP ≥ 
110 mmHg), acute coronary syndrome, myocardial infarction and acute cerebrovascular 
accident 6 month before our study, heart failure in NYHA functional class IV,  
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cardiomyopathy, glomerular filtration rate less than 60 
ml/min/1.73 m², oncology disease and who taking alcohol and 
drugs.  
Patients were examined by general clinical methods: review 
of main and additional complains, case history, life history, 
BMI calculation, measurement of blood pressure, 
determination of laboratory parameters (complete blood 
count, urinalysis, biochemiatry, glomerular filtration rate 
(GFR). Additionally, we determined levels of high-sensitivity 
C-reactive protein (hs-CRP), interleukin-1 (IL-1), interleukin-
6 (IL-6) and interleukin-10 (IL-10) in serum by immunoassay 
test kits. 12-lead electrocardiography (ECG), 24-hour 
monitoring of electrocardiogram and blood pressure, 
transthoracic echocardiography (TTE) were performed for all 
patients. 
For statistical analysis of the result we used biometric analysis 
methodology support by STATISTICA v.6.1 and MedCalс 
Statical Software v.11.5.0. software. Normal distribution was 
analyzed by the mean value (M) and mean error (m). Non-
normal distribution was analyzed by median (Me) and 
quartiles (LQ-HQ). Comparison of relative values was 
performed according to the Pearson Chi-square (2) and 
Fisher exact two-tailed (FET) criteria and the average values 
were compared to Student T-test and Mann-Whitney U-test. 
The existence of interrelationships between the data under 
investigation were established on the basis of the correlation 
analysis with the calculation of the Spearman rank correlation 
coefficients (Rs). In order to detect the predictors of rhythm 
disturbances we used the method of logistic regression and 
calculated the Odds ratio (OR) and ROC-analysis (Receiver 
Operating Characteristic) with constructing characteristic 
curves and plotting the area under the curve (AUC), 
sensitivity and specificity with 95% confidence intervals (CI). 
The difference was considered significant at p< 0, 05 (5%). 
 
3. Results and Discussion 
In our study the group consisted of 42 patients, the ratio of 
men and women among patients with permanent form of AF, 
AH, CAD and HF was 1:1, smokers-15 (35, 7%). The ratios 
of the patients admitted to the cardiology department previous 
year can be presented as follows: only once-16/42 (38.1%), 
twice-5/42 (11.9%), thrice-1/42 (2.4%). The patients who 
hadn’t been admitted earlier (till 2018) compiled 20/42 
(47.6%). The main causes of admission to the cardiology 
department were hypertensive crisis or unstable angina-6/42 
(14.3%), hear failure-14/42 (33.3%). AF was associated with 
hypertensive crisis and unstable angina in 10/42 (23.8%) 
cases, hypertensive crisis and HF–1/42 (2.3%), unstable 
angina and HF–3/42 (7.1%) cases. The simultaneous 
manifestation of the three emergences states (hypertensive 
crisis, unstable angina and HF) was founded in 3 patients 
(7.1%). 
Among the 42 patients implicated in the study, 14 (33.3%) 
were readmitted in the cardiology hospital during the year (A 
group) (Figure 1). Among them were 6 men (49.9%) and 8 
women (51.1%). The main reason for admission to the 
hospital in group A was progression of HF in 2 (14.3%) 
patients or the adaption of antiarrhythmic drug treatment in 12 
(85.7%) patients. 2 (4.8%) patients out of 42 died due to a 
sudden cardiac death. 28/42 (66,7%) (group B) patients were 




Fig 1: Number of patients undergone readmission 
 
We compared the both research groups and identified the 
indicators that were significantly different and could affected 
readmission. Such indicators were the frequency of the 
hospitalization during the previous year, the number of 
hypertensive crises and unstable angina as the main causes of 
hospitalization, New York heart association (NYHA) 
functional classification of breathlessness in angina pectoris 
patients and atrial fibrillation-related symptoms (EHRA 
score) as well (Table. 1) 
 
Table 1: Risk factor prevalence among patients of study groups 
 
Indicators A group (n=14) B group (n=28) Significant differences between groups 
Admission frequency 
for the previous year: 
0 0 20 (71.4%) 
χ2=20.68; p<0.001 
1 9 (64.3%) 7 (25.0%) 
2 4 (28.6%) 1 (3.6%) 
3 1 (7.1%) 0 
Hypertensive crisis 11 (78.6%) 9 (32.1%) p=0.008 * 
Angina pectoris 11 (78.6%) 11 (39.3%) p=0.023 * 
NYHA: 
2 1 (7.1%) 15 (53.6%) 
p=0.006 * 
3 13 (92.9%) 13 (46.4%) 
EHRA: 
 
1 points 1 (7.1%) 15 (53.6%) 
χ2=8.75; p=0.013 2 points 10 (71.4%) 9 (32.1%) 
3 points 3 (21.4% 4 (14.3%) 
Explanatory note: * -according to FET 
FET – Fisher exact two-tailed 
NYHA- New York heart association (NYHA) functional classification of breathlessness 
EHRA - atrial fibrillation-related symptoms 
 
It was established a direct correlation between readmission 
and the case frequency of admission to the cardiology 
department during the year preceded the year of study (rs = 
+0.70; p< 0.001), an EHRA scale symptoms score (rs = 
+0.38; p = 0.012), NYHA FC (rs = +0.45; p = 0.003) and the 
presence of unstable angina (rs = +0.37; p = 0.016). 
The presence of more active chronic systemic inflammation in 
patients with AF, AH, HF compared with relatively healthy 
persons has been established. The average levels of these 
parameters in patients with rhythm disturbances by type of 
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continuous AF were significantly higher in comparison with 
relatively healthy persons: levels hs-CRP (4.12 mg / L [3.51; 
6.77] vs 2.98 mg / L [2.21; 3.43], p< 0.001), IL-1 (11.21 pg / 
mL [4.64; 17.24] vs 3.48 pg / mL [1.19; 6.06], p< 0.001), IL-6 
(7.09 pg / mL [5.88; 13.77] vs. 5.03 pg / mL [3.16; 7.51], p< 
0.001), IL-10 (33.04 pg / ml [15.91; 35.54] vs 11,14 pg / ml 
[1.71; 21.91], p< 0.001). 
The analysis of hs-CRP and cytokine parameters in the study 
groups showed a direct relationship between the severity of 
chronic inflammation and patients’ readmission frequency: 
hs-CRP (rs = +0.54; p< 0.001), IL-6 (rs = +0.31; p = 0.044), 
IL-10 (rs = +0.45; p=0.003).  
Through the ROC analysis, optimal cut off points were 
determined for the studied parameters that identify the relative 
risk of readmission: cases of the admission in anamnesis area 
under the ROC curve (AUC = 0.892; 95% CІ 0.757 – 0.966; 
sensitivity = 100%; specificity = 71.4%), the presence of 
unstable angina (AUC=0.696; 95% CІ 0.535 – 0.828; 
sensitivity = 78.6%; specificity = 60.7%), EHRA ≥ 1 score 
(AUC=0.716; 95% CІ 0.555 – 0.844; sensitivity = 92.9%; 
specificity = 53.6%), NYHA FC ≥ 2 (AUC=0.732; 95% CІ 
0.573-0.857; sensitivity = 92.9%; specificity = 53.6%), levels 
of hs-CRP ≥ 4.16 mg/L in serum concentration (AUC=0.832; 
95% CІ 0.684- 0.929; sensitivity = 85.7%; specificity = 
71.4%), ІL-6 ≥ 8.35 pg / ml in serum concentration 
(AUC=0.691; 95% CІ 0.530 – 0.824; sensitivity = 71.4%; 
specificity = 75.0%), ІL-10 ≥ 35.3 pg / ml in serum 
concentration (AUC=0.774; 95% CІ 0.619 – 0.888; sensitivity 
= 64.3%; specificity = 89.3%).  
According to the results of one-factor logit-regression 
analysis, it was found that in the presence of the previous year 
admissions, the chances of admission frequencies in patients 
with a permanent form of AF, HA and HF significantly 
increased by 82.8 times (OR = 82.8; 95% CI 3.4-2011.3), and 
the probability of such event achieved Pmax. = 63.9%. 
Provided that the patient has EHRA ≥ 1 and NYHA FC ≥ 2, 
the risk increases by 15 times (HR= 15.0; 95% CI 1.6-139.9); 
with unstable angina - by 5.7 times (OR = 5.7; 95% CI 1.2-
26.2), reaching 50% probability. If the concentration of hs-
CRP in serum is determined more than 4.16 mg / L, the risk 
of readmission increases by 15.0 times (OR = 15.0; 95% CI 
2.6-87.2); the probability of the event is 60%. In IL-6 serum 
concentration composing more than 8.35 pg / mL the risk 
probability increases in 7.5 times (HR = 7.5; 95% CI 1.7-
33.1), reaching 58.8%. In conditions of an increase of IL-10 ≥ 
35.3 pg / ml, the risk increases by 15.0 times (OR = 15.0; 
95% CI 2.8-79.9); the event probability reaches 75%. 
 
4. Conclusion 
The study found that patients with permanent form AF, AH, 
SCAD and HF admitting to the cardiology department 
repeatedly increase the social and economic burden.  
It was established a direct correlation between readmission 
and the case frequency of readmission to the cardiology 
department during the year preceded the year of study, an 
EHRA scale symptoms score, NYHA FC and the presence of 
unstable angina. 
Through the ROC analysis, optimal cut off points were 
determined for the studied parameters identifing the relative 
risk of readmission: number of the readmissions in anamnesis, 
the presence of unstable angina, EHRA ≥ 1 score, NYHA FC 
≥ 2, levels of hs-CRP ≥ 4.16 mg / L, ІL-6 ≥ 8.35 pg / ml and 
ІL-10 ≥ 35.3 pg / ml in serum. 
According to the results of one-factor logit-regression 
analysis, it was found that in the presence of the previous year 
admissions, the chances of admission frequencies in patients 
with a permanent form of AF, HA and HF significantly 
increased by 82.8 times, and the probability of such event 
achieved Pmax. = 63.9%. Provided that the patients have 
EHRA ≥ 1 and FC CH for NYHA ≥ 2, the risk increases by 
15 times; with presence of unstable angina - by 5.7 times, 
reaching 50%. If the concentration of hs-CRP in serum is 
determined more than 4.16 mg / L, the risk of readmission 
increases by 15.0 times; the probability of the event is 60%. 
Provided that the level of IL-6 in serum is more than 8.35 pg / 
mL the risk probability of readmission increases by 7.5 times, 
reaching 58.8%. If IL-10 increases more than 35.3 pg / ml, the 
risk increases by 15.0 times; the probability of the event is 
75%. 
If IL-6 serum concentration composing more than 8.35 pg / 
mL the risk probability increases in 7.5 times (HR = 7.5; 95% 
CI 1.7-33.1), reaching 58.8%. In conditions of an increase of 
IL-10 ≥ 35.3 pg / ml, the risk increases by 15.0 times (OR = 
15.0; 95% CI 2.8-79.9); the event probability reaches 75%. 
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